What systemic therapy would you recommend for axillary recurrence of triple negative secretory breast cancer previously treated with mastectomy alone?

Topics: Breast Cancer • Medical Oncology • Breast Cancer, Non-metastatic

Initial path was T1cN0, and recurrence shows 2/21 ALN involved with ENE, what would you recommend for therapy?

Answer from: Medical Oncologist at Academic Institution

The type of systemic chemotherapy for locoregional recurrence of triple negative breast cancer is not standardized. Based on the CALOR trial, the dealer's choice of systemic chemotherapy reduced the risk of breast cancer recurrence specifically in triple negative breast cancer. The patient has not r...

Comments

Medical Oncologist at NYU Winthrop Hospital
KEYNOTE-522 Pembrolizumab is used in neo-adjuvant...

Related Questions